Tyson Foods and General Mills are in line for exits after meat substitute producer Beyond Meat filed to go public in a $100m initial public offering.

Dundee spinout Kinetic Discovery has been picked up by its peer Exscientia in a deal consolidating the equity of Frontier IP, which held stakes in both drug discovery companies.

Legrand has acquired its portfolio company Netatmo for an undisclosed amount, three years after the corporate led the smart home device maker's $32m series B round.

The number of flotations of companies that have previously received corporate backing has been growing over the past couple years. More interestingly, it has been companies from the life sciences sector that beat other sectors in going public.

Dell Ventures, Citi Ventures and Capital One Ventures are all set to exit endpoint security software provider after Blackberry agreed an acquisition.

Workplace micro app platform developer Sapho has been acquired by Citrix Systems having previously raised more than $26m from investors including Bloomberg Beta.

Vitec has purchased Motorola and Hantech-backed wireless semiconductor producer Amimon in a $55m acquisition that followed some $69m of funding.

Kaiser Permanente-backed respiratory device provider Vapotherm floated at the bottom of its range but raised $56m in its initial public offering.

Xbox producer Microsoft has bought the game developer, providing an exit for Gumi Ventures, which invested $4.5m in the company last year.

Merck & Co, AstraZeneca and Alexion are all in line for exits after Moderna Therapeutics, valued at $7.5bn earlier this year, filed for its initial public offering.